Episode 75: Transitioning from Retina Specialist to Industry

from Talking Euretina · host Whipsmart Media

What drives leading retina specialists to trade the clinic for corporate innovation? In this episode, Euretina Board member Kourous Rezaei speaks with Jay Duker (CEO, Eyepoint), Sascha Fauser (SVP, Roche), and Marion Munk (CSO, Gutblick Group; CMO, Isarna Therapeutics) about their transitions from clinical practice to industry. Together they share insights on leadership, research, and the evolving relationship between academia and biotechnology in shaping the future of retinal therapeutics

Episode metadata supplied by the publisher feed · Published Jan 19, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 75: Transitioning from Retina Specialist to Industry

0:00 32:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Euretina?

This episode is 32 minutes long.

When was this Talking Euretina episode published?

This episode was published on January 19, 2026.

Can I download this Talking Euretina episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!